Huang Ying 4

What Happened

• Huang Ying, CEO of Legend Biotech, sold 9,936 ordinary shares on 2026-03-25 in an open-market/private sale for total proceeds of approximately $87,139. The weighted average price reported was $8.77 per ordinary share. This sale was reported on a Form 4 filed 2026-03-27.
• This transaction was a sale to cover withholding tax obligations upon the vesting of restricted share units (i.e., routine tax-withholding sale), not an independent discretionary sale that necessarily signals a change in outlook.

Key Details

• Transaction date: 2026-03-25; Form filed: 2026-03-27.
• Shares sold: 9,936 ordinary shares; proceeds ≈ $87,139; weighted average price $8.77 per ordinary share.
• Price range noted: $8.63–$8.91 per ordinary share (equivalent to $17.26–$17.82 per ADS). The reporting person can provide a breakdown of the number of shares sold at each price on request.
• Footnotes: (F2) sale made to satisfy tax withholding on RSU vesting; (F1) issuer’s ordinary shares may be represented by ADSs (1 ADS = 2 ordinary shares).
• Shares owned after the transaction: not disclosed in the filing.
• Filing timeliness: Form 4 was filed two days after the transaction date; the filing shows no explicit late-filing notation.

Context

• Sales to satisfy tax-withholding on vested restricted share units are common and generally considered routine (they do not necessarily reflect the insider’s view of the company). For retail investors, purchases by insiders are often more informative than routine withholding sales.